215 related articles for article (PubMed ID: 33215404)
1. LncRNA DLEU1 accelerates the malignant progression of clear cell renal cell carcinoma via regulating miRNA-194-5p.
He GZ; Yu SY; Zhou QP; Chen ML; Zhang YW; Zheng Y; Zhang ZB; Han ZY; Yu J
Eur Rev Med Pharmacol Sci; 2020 Nov; 24(21):10920. PubMed ID: 33215404
[TBL] [Abstract][Full Text] [Related]
2. LINC00346 accelerates the malignant progression of colorectal cancer via competitively binding to miRNA-101-5p/MMP9.
Tong WH; Mu JF; Zhang SP
Eur Rev Med Pharmacol Sci; 2021 May; 25(9):3398. PubMed ID: 34002807
[TBL] [Abstract][Full Text] [Related]
3. LncRNA PAPAS aggravates the progression of gastric cancer through regulating miRNA-188-5p.
Shi X; You X; Zeng WC; Deng YJ; Hong HL; Huang OX; Wang MF
Eur Rev Med Pharmacol Sci; 2021 Mar; 25(6):2462. PubMed ID: 33829425
[TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA PVT1 regulates glioma proliferation, invasion, and aerobic glycolysis via miR-140-5p.
Shao Y; Chen HT; Ma QR; Zhang YW; He YQ; Liu J
Eur Rev Med Pharmacol Sci; 2020 Aug; 24(16):8249. PubMed ID: 32894529
[TBL] [Abstract][Full Text] [Related]
5. LncRNA ZEB2-AS1 promotes the proliferation, migration and invasion of esophageal squamous cell carcinoma cell through miR-574-3p/HMGA2 axis.
Xu JH; Chen RZ; Liu LY; Li XM; Wu CP; Zhou YT; Yan JD; Zhang ZY
Eur Rev Med Pharmacol Sci; 2021 May; 25(9):3397. PubMed ID: 34002806
[TBL] [Abstract][Full Text] [Related]
6. CircRNA EPB41L2 inhibits tumorigenicity of lung adenocarcinoma through regulating CDH4 by miR-211-5p.
Zhang SJ; Ma J; Wu JC; Hao ZZ; Zhang YN; Zhang YJ
Eur Rev Med Pharmacol Sci; 2021 Apr; 25(8):3150. PubMed ID: 33928597
[TBL] [Abstract][Full Text] [Related]
7. LncRNA CASC15 functions as an oncogene by sponging miR-130b-3p in bladder cancer.
Yu X; Wang ZL; Han CL; Wang MW; Jin Y; Jin XB; Xia QH
Eur Rev Med Pharmacol Sci; 2020 Jul; 24(13):7203. PubMed ID: 32706041
[TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA LINP1 promotes the malignant progression of prostate cancer by regulating p53.
Wu HF; Ren LG; Xiao JQ; Zhang Y; Mao XW; Zhou LF
Eur Rev Med Pharmacol Sci; 2021 Mar; 25(5):2158. PubMed ID: 33755947
[TBL] [Abstract][Full Text] [Related]
9. LncRNA DGCR5 promotes non-small cell lung cancer progression via sponging miR-218-5p.
Wang J; Shu HZ; Xu CY; Guo SG
Eur Rev Med Pharmacol Sci; 2020 Oct; 24(20):10303. PubMed ID: 33155263
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-191-5p promotes the development of osteosarcoma via targeting EGR1 and activating the PI3K/AKT signaling pathway.
Chen B; Zheng ZY; Yang JZ; Li XG
Eur Rev Med Pharmacol Sci; 2021 Apr; 25(8):3145. PubMed ID: 33928592
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of lncRNA SNHG7 inhibits proliferation and invasion of nasopharyngeal carcinoma cells through repressing ROCK1.
Wang L; Xu T; Cui X; Han M; Zhou LH; Wei ZX; Xu ZJ; Jiang Y
Eur Rev Med Pharmacol Sci; 2020 Aug; 24(15):7917. PubMed ID: 32767310
[TBL] [Abstract][Full Text] [Related]
12. LncRNA INHBA-AS1 promotes cell growth, migration, and invasion of oral squamous cell carcinoma by sponging miR-143-3p.
Ma WQ; Chen J; Fang W; Yang XQ; Zhu A; Zhang D; Zhong HL; Yang B; Luo Z
Eur Rev Med Pharmacol Sci; 2020 Sep; 24(18):9240. PubMed ID: 33015761
[TBL] [Abstract][Full Text] [Related]
13. LncRNA SNHG16 promotes migration and invasion through suppression of CDKN1A in clear cell renal cell carcinoma.
Liu SB; Wang HF; Xie QP; Li G; Zhou LB; Hu B
Eur Rev Med Pharmacol Sci; 2020 Jul; 24(13):7216. PubMed ID: 32706054
[TBL] [Abstract][Full Text] [Related]
14. Suppression of microRNA-101 attenuates hypoxia-induced myocardial H9c2 cell injury by targeting DIMT1-Sp1/survivin pathway.
Guo ZX; Zhou FZ; Song W; Yu LL; Yan WJ; Yin LH; Sang H; Zhang HY
Eur Rev Med Pharmacol Sci; 2020 Dec; 24(23):11986. PubMed ID: 33336713
[TBL] [Abstract][Full Text] [Related]
15. Circular RNA circCRIM1 suppresses lung adenocarcinoma cell migration, invasion, EMT, and glycolysis through regulating miR-125b-5p/BTG2 axis.
Zhang SJ; Ma J; Wu JC; Hao ZZ; Zhang YA; Zhang YJ
Eur Rev Med Pharmacol Sci; 2021 May; 25(9):3399. PubMed ID: 34002808
[TBL] [Abstract][Full Text] [Related]
16. MiRNA-146b-5p inhibits the malignant progression of gastric cancer by targeting TRAF6.
Ding JN; Zang YF; Ding YL
Eur Rev Med Pharmacol Sci; 2021 Apr; 25(8):3151. PubMed ID: 33928598
[TBL] [Abstract][Full Text] [Related]
17. MiR-135b-5p affected malignant behaviors of ovarian cancer cells by targeting KDM5B.
Ren R; Wu J; Zhou MY
Eur Rev Med Pharmacol Sci; 2020 Nov; 24(22):11469. PubMed ID: 33275209
[TBL] [Abstract][Full Text] [Related]
18. Circular RNA circ_0017247 promotes melanoma migration and invasion via targeting miR-145.
Chen Z; Kang K; Chen S; Wang S; Zhang J; Zhang XY; Chen Z
Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):8630. PubMed ID: 32964948
[TBL] [Abstract][Full Text] [Related]
19. Ceramide accumulation accelerates nucleus pulposus cells degradation by p38MAPK activation.
Wu WJ; Wang J; Liang J; Zhou Q; Liang Y
Eur Rev Med Pharmacol Sci; 2021 Aug; 25(16):5072. PubMed ID: 34486680
[TBL] [Abstract][Full Text] [Related]
20. LncRNA CASC15 promotes migration and invasion in prostate cancer via targeting miR-200a-3p.
Zhang C; Wang GX; Fu B; Zhou XC; Li Y; Li YY
Eur Rev Med Pharmacol Sci; 2020 Jul; 24(13):7215. PubMed ID: 32706053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
